Parkinson’s disease diagnosis always happens too late, when the patient already presents sympthoms. The only way to change this trend is to find new predictive biomarkers.
Exoprobes’ test platform performs early diagnostic of Parkinson’s disease before sympthoms arise. We increase patient’s quality life allowing specific and timely treatment.
Company Details
- Founded
- 2020
- Address
- Via Borgonuovo 5, Bologna,emilia Romagna 40125,italy
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- exoprobes.it
- HQ
- Bologna, Emilia Romagna
Exoprobes Questions
Exoprobes's website is exoprobes.it
Exoprobes's LinkedIn profile is https://it.linkedin.com/company/exoprobes
Exoprobes's industry is
Biotechnology Research
Exoprobes's top competitors are
Ivtech,
Remembrane Srl,
Bioridis,
Cyanagen S.r.l.,
Arta Peptidion,
Bio4life,
Generon S.p.a.,
Ngb Genetics Srl,
Byflow Srl,
Aczon Srl.
Exoprobes's categories are Biotechnology Research
Exoprobes's founding year is 2020
